🔎 Trials Near Me

Utama › Glioblastoma › Pennsylvania › Philadelphia

Kajian klinikal Glioblastoma di Philadelphia, PA

11 kajian untuk Glioblastoma sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Mengambil pesertaFasa 2
  • Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Mengambil pesertaFasa 1/2
  • Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT04094610

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma

Mengambil pesertaFasa awal 1
  • Hospital of the University of Pennsylvania, Philadelphia
  • University of Pennsylvania, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06613841

Targeted Pediatric High-Grade Glioma Therapy

Mengambil pesertaKajian pemerhatian
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Mengambil pesertaFasa 2
  • Children's Hospital of Philadelphia, Philadelphia
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Mengambil pesertaFasa 3
  • Thomas Jefferson University Hospital, Philadelphia
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

WBSI Guided Personalized Delivery of TTFields

Mengambil peserta
  • Abramson Cancer Center, Philadelphia
  • Penn Medicine, University of Pennsylvania, Philadelphia
Umur 22 ke atas · Semua jantina · Dikemas kini 6 Ogo 2026 · NCT05086497

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
  • Children's Hospital of Philadelphia, Philadelphia
Umur 1 hingga 21 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT06333899

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Mengambil pesertaFasa 1
  • Children's Hospital of Philadelphia, Philadelphia
Umur 2 hingga 21 · Semua jantina · Dikemas kini 11 Jun 2026 · NCT04732065

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Mengambil pesertaFasa 2
  • Children's Hospital of Philadelphia, Philadelphia
12 Months – 39 Years · Semua jantina · Dikemas kini 29 Mei 2026 · NCT05843253

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Philadelphia
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Glioblastoma di bandar lain

Kajian lain di Philadelphia

Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.